Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndrome

Rheumatology (Oxford). 2016 Sep;55(9):1548-55. doi: 10.1093/rheumatology/kev420. Epub 2016 Jan 20.

Abstract

SS is an autoimmune condition characterized by exocrine gland destruction, autoantibody production, immune complex deposition and systemic complications associated with lymphocytic infiltration of many organs. Genetic, environmental and viral factors play a role in disease aetiology, however, the exact mechanisms driving the immunopathogenesis of SS remain uncertain. Here we discuss a role for B cell activating factor (BAFF), whereby B cell hyperactivity and increased BAFF secretion observed in patients and animal models of the disease can be explained by the altered expression of cell-specific BAFF/BAFF receptor (BAFF-R) variants in several immune cell types. Understanding the role of BAFF/BAFF-R heterogeneity in SS pathogenesis could help to facilitate new treatment strategies for patients.

Keywords: B cell activating factor (BAFF); BAFF receptor; Sjögren’s syndrome.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Cell Activating Factor / biosynthesis
  • B-Cell Activating Factor / metabolism
  • B-Cell Activating Factor / physiology*
  • B-Cell Activation Factor Receptor / metabolism
  • B-Cell Activation Factor Receptor / physiology*
  • B-Lymphocyte Subsets / physiology
  • B-Lymphocytes / physiology
  • Cytokines / metabolism
  • Disease Models, Animal
  • Humans
  • Lymphocyte Activation
  • Membrane Microdomains / pathology
  • Sjogren's Syndrome / etiology*
  • Sjogren's Syndrome / immunology

Substances

  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • Cytokines
  • TNFSF13B protein, human